Matthieu Halfon, Raffaella Emsley, Thomas Agius, Arnaud Lyon, Sébastien Déglise, Manuel Pascual, Korkut Uygun, Heidi Yeh, Leonardo V Riella, James F Markmann, Pierre-Yves Bochud, Dela Golshayan, Alban Longchamp
{"title":"Association of Kidney Graft Long-term Outcome With Recipient Cystathionine Gamma-lyase Polymorphisms and Hydrogen Sulfide Levels: A Cohort Study.","authors":"Matthieu Halfon, Raffaella Emsley, Thomas Agius, Arnaud Lyon, Sébastien Déglise, Manuel Pascual, Korkut Uygun, Heidi Yeh, Leonardo V Riella, James F Markmann, Pierre-Yves Bochud, Dela Golshayan, Alban Longchamp","doi":"10.1097/TXD.0000000000001779","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hydrogen sulfide (H<sub>2</sub>S) produced endogenously by the <i>CTH</i> gene-encoded cystathionine gamma-lyase protects from renal ischemia-reperfusion injury in preclinical models. Here, we hypothesized that <i>CTH</i> gene polymorphisms (single nucleotide polymorphism [SNP]) and recipient H<sub>2</sub>S serum levels influence kidney graft outcomes after transplantation.</p><p><strong>Methods: </strong>We included all consecutive recipients of a first kidney transplant in the Swiss Transplant Cohort Study and with available genotyping. In addition, 192 deceased-donor kidney transplant recipients were randomly selected to measure baseline serum H<sub>2</sub>S levels. The primary endpoint was graft loss during follow-up.</p><p><strong>Results: </strong><i>CTH</i> SNPs were identified in up to 50% of the patients. During median follow-up (6.4 y, interquartile range: 3.9-9.8), graft loss was observed in 247 (9.8%) of 2518 patients. The incidence of graft loss was associated with the presence or absence of <i>CTH</i> SNPs. Specifically, rs672203 and rs10458561, increased the risk of graft loss (hazard ratio [HR]: 1.36, 95% confidence interval [CI]: 1.04-1.78, <i>P</i> = 0.02; and HR: 1.29, 95% CI: 1.0-1.66, <i>P</i> = 0.05; respectively), whereas rs113285275 was protective (HR: 0.78, 95% CI: 0.6-1.01, <i>P</i> = 0.05). Interestingly, rs672203 was associated with an increased risk of acute rejection (<i>P</i> = 0.05), whereas rs113285275 was associated with a lower risk of acute rejection (<i>P</i> = 0.01). Finally, in patients with delayed graft function, serum H<sub>2</sub>S levels correlated with lower graft dysfunction (defined as estimated glomerular filtration rate <30 mL/min/1.73 m<sup>2</sup>) (<i>P</i> = 0.05).</p><p><strong>Conclusions: </strong>Graft outcome after kidney transplantation was associated with <i>CTH</i> genotype and, to some extent, H<sub>2</sub>S serum levels. Further research is needed to define the underlying protective mechanisms.</p>","PeriodicalId":23225,"journal":{"name":"Transplantation Direct","volume":"11 5","pages":"e1779"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007866/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Direct","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/TXD.0000000000001779","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hydrogen sulfide (H2S) produced endogenously by the CTH gene-encoded cystathionine gamma-lyase protects from renal ischemia-reperfusion injury in preclinical models. Here, we hypothesized that CTH gene polymorphisms (single nucleotide polymorphism [SNP]) and recipient H2S serum levels influence kidney graft outcomes after transplantation.
Methods: We included all consecutive recipients of a first kidney transplant in the Swiss Transplant Cohort Study and with available genotyping. In addition, 192 deceased-donor kidney transplant recipients were randomly selected to measure baseline serum H2S levels. The primary endpoint was graft loss during follow-up.
Results: CTH SNPs were identified in up to 50% of the patients. During median follow-up (6.4 y, interquartile range: 3.9-9.8), graft loss was observed in 247 (9.8%) of 2518 patients. The incidence of graft loss was associated with the presence or absence of CTH SNPs. Specifically, rs672203 and rs10458561, increased the risk of graft loss (hazard ratio [HR]: 1.36, 95% confidence interval [CI]: 1.04-1.78, P = 0.02; and HR: 1.29, 95% CI: 1.0-1.66, P = 0.05; respectively), whereas rs113285275 was protective (HR: 0.78, 95% CI: 0.6-1.01, P = 0.05). Interestingly, rs672203 was associated with an increased risk of acute rejection (P = 0.05), whereas rs113285275 was associated with a lower risk of acute rejection (P = 0.01). Finally, in patients with delayed graft function, serum H2S levels correlated with lower graft dysfunction (defined as estimated glomerular filtration rate <30 mL/min/1.73 m2) (P = 0.05).
Conclusions: Graft outcome after kidney transplantation was associated with CTH genotype and, to some extent, H2S serum levels. Further research is needed to define the underlying protective mechanisms.